FDA Inspection 1257153 — Carter BloodCare
The FDA completed an inspection of Carter BloodCare on Dec 17, 2024 in Mansfield, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 17, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Mansfield, TX (United States)